<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cells</journal-id>
<journal-id journal-id-type="iso-abbrev">Cells</journal-id>
<journal-id journal-id-type="publisher-id">cells</journal-id>
<journal-title-group>
<journal-title>Cells</journal-title>
</journal-title-group>
<issn pub-type="epub">2073-4409</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30691235</article-id>
<article-id pub-id-type="pmc">6406241</article-id>
<article-id pub-id-type="doi">10.3390/cells8020090</article-id>
<article-id pub-id-type="publisher-id">cells-08-00090</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mader</surname>
<given-names>Simone</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-08-00090">1</xref>
<xref ref-type="corresp" rid="c1-cells-08-00090">*</xref>
<xref ref-type="author-notes" rid="fn1-cells-08-00090">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brimberg</surname>
<given-names>Lior</given-names>
</name>
<xref ref-type="aff" rid="af2-cells-08-00090">2</xref>
<xref ref-type="corresp" rid="c1-cells-08-00090">*</xref>
<xref ref-type="author-notes" rid="fn1-cells-08-00090">†</xref>
</contrib>
</contrib-group>
<aff id="af1-cells-08-00090"><label>1</label>Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilians University Munich, D-82152 Martinsried, Germany</aff>
<aff id="af2-cells-08-00090"><label>2</label>The Feinstein Institute for Medical Research, The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, Northwell Health System, Manhasset, NY 11030, USA</aff>
<author-notes>
<corresp id="c1-cells-08-00090"><label>*</label>Correspondence: <email>Simone.Mader@med.uni-muenchen.de</email> (S.M.); <email>lbrimberg@northwell.edu</email> (L.B.)</corresp>
<fn id="fn1-cells-08-00090">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>2</month>
<year>2019</year>
</pub-date>
<volume>8</volume>
<issue>2</issue>
<elocation-id>90</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Aquaporin-4 (AQP4) is a water channel expressed on astrocytic endfeet in the brain. The role of AQP4 has been studied in health and in a range of pathological conditions. Interest in AQP4 has increased since it was discovered to be the target antigen in the inflammatory autoimmune disease neuromyelitis optica spectrum disorder (NMOSD). Emerging data suggest that AQP4 may also be implicated in the glymphatic system and may be involved in the clearance of beta-amyloid in Alzheimer’s disease (AD). In this review, we will describe the role of AQP4 in the adult and developing brain as well as its implication for disease.</p>
</abstract>
<kwd-group>
<kwd>aquaporin-4</kwd>
<kwd>autoantibodies</kwd>
<kwd>disease</kwd>
<kwd>development</kwd>
<kwd>neuromyelitis optica spectrum disorder</kwd>
<kwd>glymphatic system</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-cells-08-00090" sec-type="intro">
<title>1. Introduction</title>
<p>AQP4 belongs to a family of channels that is selectively permeable to water. AQP 1, 4 and 9 are expressed in the mammalian brain [<xref ref-type="bibr" rid="B1-cells-08-00090">1</xref>]. Aquaporin-4 (AQP4) is the most abundant water channel in the brain, spinal cord and optic nerve and controls brain water homeostasis [<xref ref-type="bibr" rid="B2-cells-08-00090">2</xref>,<xref ref-type="bibr" rid="B3-cells-08-00090">3</xref>]. This bidirectional water channel was first described by Agre’s and Verkman´s groups [<xref ref-type="bibr" rid="B4-cells-08-00090">4</xref>,<xref ref-type="bibr" rid="B5-cells-08-00090">5</xref>] who previously named it mercury-insensitive water channel (MIWC) because it could not be inhibited by adding mercury-containing compounds [<xref ref-type="bibr" rid="B4-cells-08-00090">4</xref>]. AQP4 is most abundant in astrocytes and ependymal cells lining in the ventricles with the highest expression on perivascular astrocytes end feet that surround blood vessels in the central nervous system (CNS). Density of AQP4 is greatest on the region of the astrocyte closest to the vessel (also known as polarized expression of AQP4) [<xref ref-type="bibr" rid="B2-cells-08-00090">2</xref>,<xref ref-type="bibr" rid="B3-cells-08-00090">3</xref>]. Loss of AQP4 polarity refers to AQP4 expression being mislocalized and broadly distributed in the astrocyte, rather than being focused on the endfeet surrounding blood vessels [<xref ref-type="bibr" rid="B6-cells-08-00090">6</xref>,<xref ref-type="bibr" rid="B7-cells-08-00090">7</xref>]. Due to its particularly high expression at the blood brain barrier (BBB) and blood cerebrospinal fluid (CSF) barrier, AQP4 controls bidirectional fluid exchange [<xref ref-type="bibr" rid="B8-cells-08-00090">8</xref>].</p>
<p>A growing numbers of neurological conditions are now associated with an alteration in AQP4 expression or localization. An imbalance in water homeostasis in the brain has been associated with pathological conditions such as traumatic brain injury and stroke [<xref ref-type="bibr" rid="B9-cells-08-00090">9</xref>,<xref ref-type="bibr" rid="B10-cells-08-00090">10</xref>]. Increasing evidence suggests that AQP4 is also involved in brain inflammation, glymphatic fluid clearance, synaptic plasticity and memory formation, regulation of extracellular space (ECS) volume and potassium homeostasis [<xref ref-type="bibr" rid="B8-cells-08-00090">8</xref>,<xref ref-type="bibr" rid="B11-cells-08-00090">11</xref>,<xref ref-type="bibr" rid="B12-cells-08-00090">12</xref>]. The involvement of AQP4 in several pathogenic conditions is mainly based on findings in post mortem brain tissue, in vitro studies and the usage of AQP4 deficient rodent models.</p>
<p>A loss of AQP4 polarization in perivascular astrocytic endfeet such as occurs in many brain injuries, may result in BBB breakdown. This may be particular relevant for the aging brain and Alzheimer’s disease (AD) [<xref ref-type="bibr" rid="B13-cells-08-00090">13</xref>]. </p>
<p>In contrast to the role of AQP4 in the adult brain, little is known about the role of AQP4 during early development in the fetal brain. </p>
<p>In this review, we will discuss the role of AQP4 in health and will share some novel insights from pathological conditions involving AQP4. </p>
</sec>
<sec id="sec2-cells-08-00090">
<title>2. AQP4 and Its Role during Development</title>
<p>There are scant data about the role of AQP4 during development. Since AQP4 is expressed in the adult brain on astrocyte endfeet, AQP4 expression during development is mostly considered to be linked to the time astrocytes appear in the brain. In the early postnatal phase of development, astrocytes have been described to contribute to postnatal angiogenesis and the formation of the BBB [<xref ref-type="bibr" rid="B14-cells-08-00090">14</xref>]. Transcriptional analysis of the fetal mouse brain (embryonic day E14.5) showed AQP4 expression in proliferating progenitor cells, much less in differentiated progenitor cells, and none in neurons [<xref ref-type="bibr" rid="B15-cells-08-00090">15</xref>]. Early expression of AQP4 was further supported by a study showing that AQP4 is expressed on radial glia cells in the developing mouse brain [<xref ref-type="bibr" rid="B16-cells-08-00090">16</xref>]. Using immunohistochemistry, AQP4 expression was detected as early as embryonic day E16, yet not in a polarized expression pattern [<xref ref-type="bibr" rid="B16-cells-08-00090">16</xref>]. A functional role of embryonic AQP4 has not been studied so far. One study reported the unexpected occurrence of sporadic obstructive hydrocephalus in a small subset of AQP4 deficient mice [<xref ref-type="bibr" rid="B17-cells-08-00090">17</xref>]. Histological analysis of those offspring revealed aqueductal stenosis, which blocks the CSF flow in the ventricular system, as well as ependymal disorganization. This study suggests a possible involvement of AQP4 in the pathogenesis of aqueduct stenosis, but does not determine if this occurs during neurodevelopment or occurs only later on in aged mice.</p>
</sec>
<sec id="sec3-cells-08-00090">
<title>3. AQP4 and Its Role in the Adult Brain</title>
<p>In the CNS, AQP4 is highly expressed in the perivascular astrocyte foot processes and glial limiting membrane and at lower levels in perisynaptic astrocytic processes [<xref ref-type="bibr" rid="B2-cells-08-00090">2</xref>,<xref ref-type="bibr" rid="B3-cells-08-00090">3</xref>,<xref ref-type="bibr" rid="B18-cells-08-00090">18</xref>]. Thus, AQP4 is expressed at very dense levels at the BBB, however it is also expressed at areas of the CNS that lack a BBB, such as the circumventricular organs [<xref ref-type="bibr" rid="B2-cells-08-00090">2</xref>,<xref ref-type="bibr" rid="B3-cells-08-00090">3</xref>]. </p>
<p>AQP4 monomers are ~30 kDa [<xref ref-type="bibr" rid="B19-cells-08-00090">19</xref>]. Each monomer consist of 6 transmembrane helices and 2 helices that do not span the membrane entirely [<xref ref-type="bibr" rid="B18-cells-08-00090">18</xref>]. Each monomer has a central aqueous pore. AQP4 is expressed as a tetramer in the plasma membrane [<xref ref-type="bibr" rid="B20-cells-08-00090">20</xref>]. AQP4 exists as 2 major isoforms, M1 and M23 which differ in their translation start sites from methionine M1 (323 amino acids) or methionine M23 (301 amino acids) [<xref ref-type="bibr" rid="B21-cells-08-00090">21</xref>]. Tetramers comprised of M23 form higher order structures, called orthogonal arrays of particles (OAP), which are crystal-like supramolecular assemblies in the plasma membrane [<xref ref-type="bibr" rid="B18-cells-08-00090">18</xref>,<xref ref-type="bibr" rid="B22-cells-08-00090">22</xref>,<xref ref-type="bibr" rid="B23-cells-08-00090">23</xref>]. OAP may consist of co-expressed M1-M23 AQP4 heterotetramers [<xref ref-type="bibr" rid="B24-cells-08-00090">24</xref>]. It was suggested that OAP might enhance water permeability, alter cell-cell adhesion and facilitate AQP4 polarization to astrocyte endfeet [<xref ref-type="bibr" rid="B25-cells-08-00090">25</xref>,<xref ref-type="bibr" rid="B26-cells-08-00090">26</xref>,<xref ref-type="bibr" rid="B27-cells-08-00090">27</xref>], yet the biological significance remains unknown [<xref ref-type="bibr" rid="B28-cells-08-00090">28</xref>]. OAP is the target of anti-AQP4 antibodies in neuromyelitis optica spectrum disorder (NMOSD), in which antibodies target specifically the OAP rather than monomeric M1 AQP4 [<xref ref-type="bibr" rid="B29-cells-08-00090">29</xref>,<xref ref-type="bibr" rid="B30-cells-08-00090">30</xref>,<xref ref-type="bibr" rid="B31-cells-08-00090">31</xref>,<xref ref-type="bibr" rid="B32-cells-08-00090">32</xref>] (see further discussion below).</p>
<p>In addition to the relevance of OAP, little is known about the regulation of the polarized expression of AQP4 at the perivascular endfeet. It has been hypothesized that AQP4 interacts with α-syntrophin or agrin, which both show polarized expression in astrocyte endfoot processes [<xref ref-type="bibr" rid="B33-cells-08-00090">33</xref>]. Contact by astrocytes with endothelial and pial cells may also influence AQP4 polarization, as loss of these contacts in pathological conditions may disturb AQP4 polarization [<xref ref-type="bibr" rid="B34-cells-08-00090">34</xref>,<xref ref-type="bibr" rid="B35-cells-08-00090">35</xref>].</p>
<sec>
<title>Insights from AQP4 Deficient Mice</title>
<p>Constitutive AQP4 deficient mice as well as glial-conditional AQP4 deficient mice have been used to understand the role of AQP4 in the brain [<xref ref-type="bibr" rid="B7-cells-08-00090">7</xref>,<xref ref-type="bibr" rid="B36-cells-08-00090">36</xref>].</p>
<p>AQP4 deficient mice revealed a role for AQP4 in cognition and memory. These mice show cognitive deficit in the object location memory test [<xref ref-type="bibr" rid="B37-cells-08-00090">37</xref>] and a spatial memory impairment in the Morris water maze [<xref ref-type="bibr" rid="B38-cells-08-00090">38</xref>]. </p>
<p>One study suggested that AQP4 deficient mice have an impaired BBB, decreased tight junction proteins and swollen astrocyte endfeet [<xref ref-type="bibr" rid="B39-cells-08-00090">39</xref>], yet, other studies could not replicate these findings and observed no alterations in the BBB [<xref ref-type="bibr" rid="B36-cells-08-00090">36</xref>,<xref ref-type="bibr" rid="B40-cells-08-00090">40</xref>]. </p>
<p>AQP4 deficient mice show a more pronounced phenotype under certain insults or injury. When the role of AQP4 in brain water balance was studied in non-stressed conditions, no obvious change in water homeostasis was observed in vivo [<xref ref-type="bibr" rid="B35-cells-08-00090">35</xref>]. In contrast, AQP4 deficient mice exposed to stress conditions often show either worse outcomes or beneficial effects depending on the disease model. AQP4 deficient mice have a better survival in an acute water intoxication model for brain edema [<xref ref-type="bibr" rid="B41-cells-08-00090">41</xref>], since in this model AQP4 is facilitating water movement into the brain across an intact BBB. In contrast, AQP4 deficient mice with vasogenic edema have a worse outcome with increased brain swelling, as in this pathological condition, AQP4 is required for edema resolution [<xref ref-type="bibr" rid="B42-cells-08-00090">42</xref>].</p>
</sec>
</sec>
<sec id="sec4-cells-08-00090">
<title>4. AQP4 during Disease</title>
<sec id="sec4dot1-cells-08-00090">
<title>4.1. Role of AQP4 in Inflammation</title>
<sec>
<title>Autoantibodies to Astrocytic AQP4 in NMOSD and Its Disease Spectrum</title>
<p>Over recent years, interest in AQP4 has increased due to the discovery that it is the target antigen in the neurological autoimmune disease Neuromyelitis spectrum disorder (NMOSD) [<xref ref-type="bibr" rid="B43-cells-08-00090">43</xref>,<xref ref-type="bibr" rid="B44-cells-08-00090">44</xref>]. NMOSD is an autoimmune astrocytophathy commonly characterized by astrocyte loss, demyelination in the spinal cord, optic nerve and brain. Typically patients present with demyelinating lesions spanning three or more vertebral segments. Around 80% of NMOSD patients harbor autoantibodies that target AQP4 (AQP4-IgG) in the brain. These antibodies were first discovered upon incubation of serum samples with rodent tissue which resulted in a perivascular binding pattern [<xref ref-type="bibr" rid="B43-cells-08-00090">43</xref>]. Because antibodies to AQP4 are not found in serum of healthy controls and multiple sclerosis (MS) patients [<xref ref-type="bibr" rid="B29-cells-08-00090">29</xref>,<xref ref-type="bibr" rid="B45-cells-08-00090">45</xref>], their presence is a diagnostic criterion for NMOSD [<xref ref-type="bibr" rid="B46-cells-08-00090">46</xref>,<xref ref-type="bibr" rid="B47-cells-08-00090">47</xref>], and allows early diagnosis as the clinical presentation of NMOSD patients can resemble MS and other neurological disease. Since the course of treatment for NMOSD patients is different than from MS, early correct diagnosis is critical. For example, Interferon beta treatment, commonly used for treating MS can worsen the disease outcome of NMOSD patients [<xref ref-type="bibr" rid="B48-cells-08-00090">48</xref>]. </p>
<p>As the presence of AQP4-IgG is an important biomarker for NMOSD, which can predict disease development [<xref ref-type="bibr" rid="B46-cells-08-00090">46</xref>,<xref ref-type="bibr" rid="B47-cells-08-00090">47</xref>] and allows faster initiation of appropriate treatment, there has been a strong focus on assay development [<xref ref-type="bibr" rid="B49-cells-08-00090">49</xref>]. AQP4-IgG antibodies are detected with highest sensitivity and specificity using a live cell based assay [<xref ref-type="bibr" rid="B50-cells-08-00090">50</xref>,<xref ref-type="bibr" rid="B51-cells-08-00090">51</xref>] in which human embryonic kidney cells (HEK cells) are transfected to express a fluorochrome-tagged M23 AQP4 on their cell surface to closely resemble the native conformation of AQP4 on astrocytes. Serum from patients is then incubated with the cells, and co-localization of human IgG and AQP4 is assessed [<xref ref-type="bibr" rid="B29-cells-08-00090">29</xref>,<xref ref-type="bibr" rid="B52-cells-08-00090">52</xref>]. </p>
<p>Cell based assays are now considered the gold standard for AQP4-IgG testing [<xref ref-type="bibr" rid="B29-cells-08-00090">29</xref>,<xref ref-type="bibr" rid="B30-cells-08-00090">30</xref>,<xref ref-type="bibr" rid="B31-cells-08-00090">31</xref>,<xref ref-type="bibr" rid="B32-cells-08-00090">32</xref>,<xref ref-type="bibr" rid="B53-cells-08-00090">53</xref>]. AQP4 antibodies target primarily the extracellular part of the M23-AQP4 isoform rather than the extracellular part of full length M1 AQP4 isoform [<xref ref-type="bibr" rid="B53-cells-08-00090">53</xref>,<xref ref-type="bibr" rid="B54-cells-08-00090">54</xref>]. This is associated with the ability of M23 AQP4 to form OAP. Patients’ antibodies bind with high affinity to the OAP, as has been shown for monoclonal AQP4-IgG as well as for AQP4-IgG positive serum samples [<xref ref-type="bibr" rid="B29-cells-08-00090">29</xref>,<xref ref-type="bibr" rid="B55-cells-08-00090">55</xref>]. Fryer and colleagues noted that in flow cytometry assay, nonspecific binding was observed with some samples when cells were transfected with M23-AQP4, but not when transfected with a combination of M1/M23 AQP4 [<xref ref-type="bibr" rid="B56-cells-08-00090">56</xref>]. Nevertheless, cells transfected with M23-AQP4 are considered to detect the presence of AQP4-IgG in serum with high sensitivity and specificity [<xref ref-type="bibr" rid="B29-cells-08-00090">29</xref>,<xref ref-type="bibr" rid="B49-cells-08-00090">49</xref>]. </p>
<p>It is suggested that the higher binding affinity of AQP4-IgG to OAP is associated with structural changes in the AQP4 epitope upon array assembly [<xref ref-type="bibr" rid="B18-cells-08-00090">18</xref>] or enhanced avidity binding to a multivalent antigen [<xref ref-type="bibr" rid="B57-cells-08-00090">57</xref>].</p>
<p>It is not clear whether the antibodies by themselves are sufficient to cause pathology, or whether ongoing inflammation is required. CNS reactive T cells may be important to breach the BBB and allow antibody entry into the brain [<xref ref-type="bibr" rid="B58-cells-08-00090">58</xref>]. In rodent models of NMOSD, encephalitogenic CNS reactive T cells are used to open the BBB and to allow human AQP4-IgG to penetrate the brain [<xref ref-type="bibr" rid="B59-cells-08-00090">59</xref>,<xref ref-type="bibr" rid="B60-cells-08-00090">60</xref>,<xref ref-type="bibr" rid="B61-cells-08-00090">61</xref>,<xref ref-type="bibr" rid="B62-cells-08-00090">62</xref>]. It has also been suggested that pathogenic T cells may not only be involved in opening the BBB, but contribute to disease pathogenesis since AQP4 reactive T cells that were generated in AQP4 knockout mice result in NMOSD like lesion when transferred to wild type mice [<xref ref-type="bibr" rid="B63-cells-08-00090">63</xref>].</p>
<p>It has also been proposed that patients with NMOSD have, in addition to anti-AQP4 antibodies, anti-endothelial antibodies that can breach the BBB [<xref ref-type="bibr" rid="B64-cells-08-00090">64</xref>]. Using a novel proteomic approach investigators showed that brain microvasculature endothelial antibodies target glucose regulated protein 78 (GRP78). Repeated systemic injection of rodents with patient derived monoclonal antibodies to GRP78 breaches the BBB and allows AQP4-IgG to enter the CNS. This would suggest that AQP4-IgG can be pathogenic to the brain, even in absence of pathogenic T cells or BBB insults such as infection. A recent study demonstrated for the first time that a circulating rodent high affinity anti-AQP4 monoclonal antibody that was injected into rats can enter the CNS by itself and cause tissue destruction without addition of pathogenic T cells or active complement [<xref ref-type="bibr" rid="B65-cells-08-00090">65</xref>]. However, this has not been shown for human derived AQP4-IgG so far, and so may be limited to few antibodies or to an unidentified aspect of the experimental protocol. Another study showed that AQP4-IgG binding to astrocytes induces Interleukin-6 (IL6) production, which might decrease BBB function, increase chemokine production and result in increased leukocyte transmigration, and a feed-forward pathologic process (<xref ref-type="fig" rid="cells-08-00090-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B66-cells-08-00090">66</xref>].</p>
<p>Several mechanisms can account for the tissue damage following the binding of AQP4-IgG to AQP4 expressed in the brain. The mechanism for which there is most evidence is complement dependent cytotoxicity (CDC) [<xref ref-type="bibr" rid="B68-cells-08-00090">68</xref>,<xref ref-type="bibr" rid="B69-cells-08-00090">69</xref>], in which AQP4-IgG activates complement, leading to irreversible astrocyte loss through the formation of the membrane attack complex (MAC). This mechanism is supported by the fact that most AQP4-IgG are IgG1 [<xref ref-type="bibr" rid="B69-cells-08-00090">69</xref>], which is potent at complement activation. Complement deposition products are indeed present in the brain of NMOSD patients [<xref ref-type="bibr" rid="B70-cells-08-00090">70</xref>], and early clinical trials suggest a benefit of complement inhibitors in NMOSD [<xref ref-type="bibr" rid="B71-cells-08-00090">71</xref>].</p>
<p>Some studies have suggested that rodent complement, particularly mouse, may not be sufficient to activate human antibody mediated CDC [<xref ref-type="bibr" rid="B72-cells-08-00090">72</xref>,<xref ref-type="bibr" rid="B73-cells-08-00090">73</xref>]. Human AQP4-IgG that was directly injected into the brain of rodents required the addition of human complement to induce pathogenicity [<xref ref-type="bibr" rid="B73-cells-08-00090">73</xref>]. However, one has to keep in mind that under quiescent conditions, such as in models in which antibody is injected directly to the brain, there may be less complement in the brain parenchyma than in NMOSD patients [<xref ref-type="bibr" rid="B74-cells-08-00090">74</xref>] with a BBB breach or under inflammatory conditions. </p>
<p>New evidence suggests that AQP4-IgG can also induce complement independent pathologies [<xref ref-type="bibr" rid="B65-cells-08-00090">65</xref>,<xref ref-type="bibr" rid="B67-cells-08-00090">67</xref>,<xref ref-type="bibr" rid="B68-cells-08-00090">68</xref>,<xref ref-type="bibr" rid="B75-cells-08-00090">75</xref>]. Brain lesions, with or without complement deposition, can be found in NMOSD patients, even within the same patient, suggesting that different mechanisms of AQP4-IgG may act concurrently. Little is known about the mechanism by which AQP4-IgG mediates brain lesions in the absence of complement activation [<xref ref-type="bibr" rid="B75-cells-08-00090">75</xref>]. An in vitro study of cultured human astrocytes provided evidence that both complement dependent and independent astrocytopathy can occur as AQP4-IgG may decrease antigen density in the absence of complement, which could be partially reversed by the removal of IgG from the culture [<xref ref-type="bibr" rid="B68-cells-08-00090">68</xref>]. This may alter astrocyte function. In an in vivo study, IgG from an NMOSD patient was passively transferred to mice with a compromised BBB by prior LPS injection. The mice showed AQP4 astrocyte loss in the spinal cord in the absence of complement activation [<xref ref-type="bibr" rid="B67-cells-08-00090">67</xref>]. There was a massive increase of Iba1 positive microglial cells found in close proximity to the astrocytes [<xref ref-type="bibr" rid="B67-cells-08-00090">67</xref>]. This study proposed a mechanism in which AQP4-IgG acts through antibody dependent cell mediated cytotoxicity (ADCC) by activating microglia expressing FcR including FcγRI, FcγRII, and FcγRIII. Interestingly, anti-AQP4-IgG engineered to have nine fold stronger CDC, but no ADCC, produced much less pathology than wildtype AQP4-IgG in one study [<xref ref-type="bibr" rid="B76-cells-08-00090">76</xref>].</p>
<p>Understanding the mechanisms of tissue destruction caused by AQP4-IgG will pave the way for therapeutic intervention. To date most patients with NMOSD receive immunosuppressive medications. Acute symptoms are commonly treated with Methylprednisolone or plasma exchange [<xref ref-type="bibr" rid="B71-cells-08-00090">71</xref>,<xref ref-type="bibr" rid="B77-cells-08-00090">77</xref>,<xref ref-type="bibr" rid="B78-cells-08-00090">78</xref>]. As preventative therapy, the monoclonal antibody Rituximab, targeting CD20 positive B cells [<xref ref-type="bibr" rid="B71-cells-08-00090">71</xref>], but not antibody secreting plasma cells is commonly used. Patients show improvement with Rituximab therapy [<xref ref-type="bibr" rid="B79-cells-08-00090">79</xref>], despite persistent AQP4-IgG levels [<xref ref-type="bibr" rid="B80-cells-08-00090">80</xref>,<xref ref-type="bibr" rid="B81-cells-08-00090">81</xref>]. Since AQP4-IgG persist following rituximab and patients show beneficial effect, the question remains if AQP4-IgG by itself can cause damage. It is possible that Rituximab may have a different effect, such as depleting B cells that present antigen to pathogenic T cells, or increasing T regulatory cells (Treg) [<xref ref-type="bibr" rid="B82-cells-08-00090">82</xref>,<xref ref-type="bibr" rid="B83-cells-08-00090">83</xref>].</p>
<p>Blocking the binding of pathogenic AQP4-IgG through administration of non-pathogenic AQP4-IgG that lacks CDC and ADCC is emerging as potential therapeutic intervention in NMOSD [<xref ref-type="bibr" rid="B84-cells-08-00090">84</xref>], which would allow avoiding immunosuppressive therapy. If, however, AQP4-IgG acts also through mechanisms other than CDC or ADCC, this type of treatment may not be sufficient to mitigate all pathology. The alternative would be to administer peptide mimeotopes to block pathogenic AQP4-IgG. Such an approach was been suggested for neutralization of brain-reactive antibodies in Neurospsychiatric Systemic Lupus Erythematosus. Blocking the pathogenic epitope may be a challenge as, however there may be multiple epitopes targeted by patients’ antibodies [<xref ref-type="bibr" rid="B85-cells-08-00090">85</xref>].</p>
</sec>
</sec>
<sec id="sec4dot2-cells-08-00090">
<title>4.2. Role of AQP4 in Controlling Brain-Water Balance</title>
<sec>
<title>AQP4 and Hydrocephalus</title>
<p>Hydrocephalus is a pathologic condition in which increased CSF accumulation in the ventricles often results in increased pressure. Untreated hydrocephalus can lead to brain swelling, brain damage and death. Hydrocephalus is usually caused by impaired clearance of CSF outflow from the brain into the circulatory system. </p>
<p>Animal models have implicated AQP4 in both hydrocephalus initiation and resolution. The role of AQP4 depends on the disease stage and brain region. In models that use kaolin to induce acute hydrocephalus, there is an increase of AQP4 expression [<xref ref-type="bibr" rid="B86-cells-08-00090">86</xref>,<xref ref-type="bibr" rid="B87-cells-08-00090">87</xref>]. In a rodent model where hydrocephalus is induced by <sc>l</sc>-alysophosphatidylcholinestearoyl injection, upregulation in AQP4 expression in astrocytes, both on astrocytic endfeet and on the entire membrane of the astrocyte was recorded [<xref ref-type="bibr" rid="B88-cells-08-00090">88</xref>]. AQP4 deficient mice exhibit a sporadic rate of spontaneous hydrocephalus [<xref ref-type="bibr" rid="B17-cells-08-00090">17</xref>] and kaolin induced hydrocephalus in AQP4 deficient mice results in an accelerated progression of hydrocephalus [<xref ref-type="bibr" rid="B89-cells-08-00090">89</xref>]. In patients with congenital hydrocephalus, AQP4, measured by Western blot and ELISA, is elevated in CSF and in the parenchyma [<xref ref-type="bibr" rid="B90-cells-08-00090">90</xref>]. In addition, hydrocephalus has been reported in AQP4-IgG seropositive NMOSD patients [<xref ref-type="bibr" rid="B91-cells-08-00090">91</xref>] as well as vasogenic edema that manifests as posterior reversible encephalopathy syndrome [<xref ref-type="bibr" rid="B92-cells-08-00090">92</xref>]. </p>
<p>While it is clear that AQP4 has a role in hydrocephalus, it remains unclear whether AQP4 has a protective or deleterious effect. It may contribute to hydrocephalus development at the initial disease stage or be important for edema resolution at a later time point. In addition, AQP4 is considered to have different roles for cytotoxic brain edema, vasogenic brain edema, and hydrocephalus, which may reflect to the different sites where water is accumulated in these conditions. </p>
<p>This needs to be resolved before addressing a potential treatment approach that would limit water flow into the brain and accelerate outflow into the systemic circulation by modulating AQP4 and might diminish the need for a surgical intervention. </p>
</sec>
</sec>
<sec id="sec4dot3-cells-08-00090">
<title>4.3. Role of AQP4 in Glymphatic Clearance, Synaptic Plasticity and Memory</title>
<sec>
<title>AQP4 and Alzheimer Diseases </title>
<p>With the elucidation of the glymphatic (glial lymphatic) system in 2012 as a system of waste clearance for the brain [<xref ref-type="bibr" rid="B93-cells-08-00090">93</xref>], several studies have associated a breakdown of the glymphatic pathway in different neurodegenerative diseases including AD (<xref ref-type="fig" rid="cells-08-00090-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B94-cells-08-00090">94</xref>]. It is believed that the recirculation of CSF flow is driven by active fluid transport through the brain parenchyma from para-arterial to para-venous spaces and that AQP4 supports the clearance of interstitial solutes including beta-amyloid and tau to prevent their aggregation. Accumulation of beta-amyloid is a hallmark of AD and can begin years before disease onset [<xref ref-type="bibr" rid="B95-cells-08-00090">95</xref>]. The glymphatic system is proposed to be most effective during sleep and dysfunctional sleep is further associated with beta-amyloid accumulation [<xref ref-type="bibr" rid="B93-cells-08-00090">93</xref>,<xref ref-type="bibr" rid="B96-cells-08-00090">96</xref>]. It has been shown that glymphatic function is reduced in the mid- to late-stage of AD due to the loss of polarity of AQP4 at the astrocyte endfeet [<xref ref-type="bibr" rid="B13-cells-08-00090">13</xref>]. A recent study suggested that people with certain genetic variations in AQP4 who have poor sleep patterns have more beta-amyloid deposition in the brain due to a dysfunctional glymphatic system [<xref ref-type="bibr" rid="B97-cells-08-00090">97</xref>]. The role of AQP4 in the glymphatic system should be further investigated [<xref ref-type="bibr" rid="B98-cells-08-00090">98</xref>]. </p>
<p>AQP4 is also implicated in regulating glutamate transporter-1 (GLT-1) function. Astrocytes in AQP4 deficient mice have reduced GLT-1 levels as well as reduced glutamate clearance, which in turns affects synaptic plasticity and memory since function can be rescued by a potent GLT-1 stimulator [<xref ref-type="bibr" rid="B99-cells-08-00090">99</xref>]. This further emphasizes that AQP4 may be an interesting and novel target in many diseases.</p>
</sec>
</sec>
</sec>
<sec id="sec5-cells-08-00090">
<title>5. Conclusions</title>
<p>Alterations in AQP4 expression or loss of polarization, or both, is now reported in many diseases (<xref ref-type="table" rid="cells-08-00090-t001">Table 1</xref>). In some conditions, such as hydrocephalus and stroke, the role of AQP4 has been studied for some time, while, in other diseases such as AD the role for AQP4 emerged only recently.</p>
<p>AQP4 function, particularly regarding its role in brain water balance, may differ in different brain areas. Moreover the consequence of AQP4 dysfunction may depend on the stage of the disease that is being studied. Rodent models trying to elucidate the role of AQP4 in different disease models can therefore be conflicting. Moreover, it is emerging that AQP4 helps regulate glutamate levels and GLT-1 expression [<xref ref-type="bibr" rid="B102-cells-08-00090">102</xref>]. More will be learned about changes in brain homeostasis following dysfunction of AQP4 in the coming years. </p>
<p>AQP4 inhibitors or down regulators may provide future potential treatment of some conditions such as for cytotoxic brain edema [<xref ref-type="bibr" rid="B103-cells-08-00090">103</xref>]. 2-(nicotinamide)-1,3,4-thiadiazole (TGN-020) was shown to serve as a potent AQP4 inhibitor in an ischemic rodent stroke model [<xref ref-type="bibr" rid="B104-cells-08-00090">104</xref>]. In contrast, enhancers of AQP4 expression may be beneficial in reducing vasogenic brain swelling.</p>
<p>Therapeutic strategies need to address access of AQP4 modulators across a functionally intact BBB, since not all pathological conditions are associated with impaired BBB. Aquaporumab is an example of an AQP4-targeted antibody therapeutics [<xref ref-type="bibr" rid="B84-cells-08-00090">84</xref>]. This is a non-pathogenic- AQP4-IgG lacking CDC and ADCC, so it can bind AQP4 without causing NMO lesions, blocking the ability of pathogenic AQP4-IgG to bind. AQP4 blocking antibodies as well as AQP4-IgG enzymatic inactivation are in preclinical development, and it will be important to determine when and where it traverses the BBB.</p>
<p>It is abundantly clear that the functions of AQP4 in the CNS are more diverse and more complex than previously appreciated. Targeted therapeutics with maximum benefit and limited toxicity will depend on a thorough understanding of the biology or AQP4 in health and in the myriad pathologic conditions that we know include aberrant AQP4 expression.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank Betty Diamond for helpful discussions and review of comments on the manuscript. The authors thank Benjamin Obholzer for image design.</p>
</ack>
<notes>
<title>Funding</title>
<p>The Nancy Lurie Marks Family Foundation, NIH SIBR1 R43 HD092128-01, LB is the recipient of young investigator award from American Autoimmune Related Diseases Association, Inc. (AARDA).</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-cells-08-00090">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badaut</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brunet</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Regli</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Aquaporins in the brain: From aqueduct to “multi-duct”</article-title>
<source/>Metab. Brain Dis.
          <year>2007</year>
<volume>22</volume>
<fpage>251</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1007/s11011-007-9057-2</pub-id>
<pub-id pub-id-type="pmid">17701333</pub-id>
</element-citation>
</ref>
<ref id="B2-cells-08-00090">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rash</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Yasumura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1998</year>
<volume>95</volume>
<fpage>11981</fpage>
<lpage>11986</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.95.20.11981</pub-id>
<pub-id pub-id-type="pmid">9751776</pub-id>
</element-citation>
</ref>
<ref id="B3-cells-08-00090">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielsen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nagelhus</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Amiry-Moghaddam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bourque</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
</person-group>
<article-title>Specialized membrane domains for water transport in glial cells: High-resolution immunogold cytochemistry of aquaporin-4 in rat brain</article-title>
<source/>J. Neurosci.
          <year>1997</year>
<volume>17</volume>
<fpage>171</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-01-00171.1997</pub-id>
<pub-id pub-id-type="pmid">8987746</pub-id>
</element-citation>
</ref>
<ref id="B4-cells-08-00090">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Skach</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Matthay</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Molecular cloning of a mercurial-insensitive water channel expressed in selected water-transporting tissues</article-title>
<source/>J. Biol. Chem.
          <year>1994</year>
<volume>269</volume>
<fpage>5497</fpage>
<lpage>5500</lpage>
<pub-id pub-id-type="pmid">7509789</pub-id>
</element-citation>
</ref>
<ref id="B5-cells-08-00090">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>R.V.</given-names>
</name>
<name>
<surname>Preston</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Guggino</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Molecular characterization of an aquaporin cDNA from brain: Candidate osmoreceptor and regulator of water balance</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1994</year>
<volume>91</volume>
<fpage>13052</fpage>
<lpage>13056</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.91.26.13052</pub-id>
<pub-id pub-id-type="pmid">7528931</pub-id>
</element-citation>
</ref>
<ref id="B6-cells-08-00090">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murlidharan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Crowther</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Reardon</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Asokan</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain</article-title>
<source/>JCI Insight
          <year>2016</year>
<volume>1</volume>
<fpage>e88034</fpage>
<pub-id pub-id-type="doi">10.1172/jci.insight.88034</pub-id>
<pub-id pub-id-type="pmid">27699236</pub-id>
</element-citation>
</ref>
<ref id="B7-cells-08-00090">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Auguste</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Three distinct roles of aquaporin-4 in brain function revealed by knockout mice</article-title>
<source/>Biochim. Biophys. Acta
          <year>2006</year>
<volume>1758</volume>
<fpage>1085</fpage>
<lpage>1093</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamem.2006.02.018</pub-id>
<pub-id pub-id-type="pmid">16564496</pub-id>
</element-citation>
</ref>
<ref id="B8-cells-08-00090">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagelhus</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
</person-group>
<article-title>Physiological roles of aquaporin-4 in brain</article-title>
<source/>Physiol. Rev.
          <year>2013</year>
<volume>93</volume>
<fpage>1543</fpage>
<lpage>1562</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00011.2013</pub-id>
<pub-id pub-id-type="pmid">24137016</pub-id>
</element-citation>
</ref>
<ref id="B9-cells-08-00090">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Z.A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>2254</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-02505-6</pub-id>
<pub-id pub-id-type="pmid">28533515</pub-id>
</element-citation>
</ref>
<ref id="B10-cells-08-00090">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aoki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Uchihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wakayama</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Enhanced expression of aquaporin 4 in human brain with infarction</article-title>
<source/>Acta Neuropathol.
          <year>2003</year>
<volume>106</volume>
<fpage>121</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-003-0709-y</pub-id>
<pub-id pub-id-type="pmid">12715185</pub-id>
</element-citation>
</ref>
<ref id="B11-cells-08-00090">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubbard</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Szu</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>D.K.</given-names>
</name>
</person-group>
<article-title>The role of aquaporin-4 in synaptic plasticity, memory and disease</article-title>
<source/>Brain Res. Bull.
          <year>2018</year>
<volume>136</volume>
<fpage>118</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresbull.2017.02.011</pub-id>
<pub-id pub-id-type="pmid">28274814</pub-id>
</element-citation>
</ref>
<ref id="B12-cells-08-00090">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Aquaporin 4 and neuromyelitis optica</article-title>
<source/>Lancet Neurol.
          <year>2012</year>
<volume>11</volume>
<fpage>535</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(12)70133-3</pub-id>
<pub-id pub-id-type="pmid">22608667</pub-id>
</element-citation>
</ref>
<ref id="B13-cells-08-00090">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeppenfeld</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haswell</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>D’Abreo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Murchison</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Grafe</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Woltjer</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Kaye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Iliff</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains</article-title>
<source/>JAMA Neurol.
          <year>2017</year>
<volume>74</volume>
<fpage>91</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2016.4370</pub-id>
<pub-id pub-id-type="pmid">27893874</pub-id>
</element-citation>
</ref>
<ref id="B14-cells-08-00090">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reemst</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Noctor</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Lucassen</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Hol</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>The Indispensable Roles of Microglia and Astrocytes during Brain Development</article-title>
<source/>Front. Hum. Neurosci.
          <year>2016</year>
<volume>10</volume>
<fpage>566</fpage>
<pub-id pub-id-type="pmid">27877121</pub-id>
</element-citation>
</ref>
<ref id="B15-cells-08-00090">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aprea</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Calegari</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Long non-coding RNAs in corticogenesis: Deciphering the non-coding code of the brain</article-title>
<source/>EMBO J.
          <year>2015</year>
<volume>34</volume>
<fpage>2865</fpage>
<lpage>2884</lpage>
<pub-id pub-id-type="doi">10.15252/embj.201592655</pub-id>
<pub-id pub-id-type="pmid">26516210</pub-id>
</element-citation>
</ref>
<ref id="B16-cells-08-00090">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fallier-Becker</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vollmer</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Noell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wolburg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Onset of aquaporin-4 expression in the developing mouse brain</article-title>
<source/>Int. J. Dev. Neurosci.
          <year>2014</year>
<volume>36</volume>
<fpage>81</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2014.06.001</pub-id>
<pub-id pub-id-type="pmid">24915007</pub-id>
</element-citation>
</ref>
<ref id="B17-cells-08-00090">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Sporadic obstructive hydrocephalus in Aqp4 null mice</article-title>
<source/>J. Neurosci. Res.
          <year>2009</year>
<volume>87</volume>
<fpage>1150</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.21927</pub-id>
<pub-id pub-id-type="pmid">18951529</pub-id>
</element-citation>
</ref>
<ref id="B18-cells-08-00090">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Aquaporin water channels in the nervous system</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2013</year>
<volume>14</volume>
<fpage>265</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3468</pub-id>
<pub-id pub-id-type="pmid">23481483</pub-id>
</element-citation>
</ref>
<ref id="B19-cells-08-00090">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujiyoshi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The AQP structure and functional implications</article-title>
<source/>Handb. Exp. Pharmacol.
          <year>2009</year>
<fpage>31</fpage>
<lpage>56</lpage>
</element-citation>
</ref>
<ref id="B20-cells-08-00090">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sandstrom</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chorny</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Harries</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Miercke</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Stroud</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>7437</fpage>
<lpage>7442</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0902725106</pub-id>
<pub-id pub-id-type="pmid">19383790</pub-id>
</element-citation>
</ref>
<ref id="B21-cells-08-00090">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Verdijk</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Merkx</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rijss</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Deen</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>The human AQP4 gene: Definition of the locus encoding two water channel polypeptides in brain</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1996</year>
<volume>93</volume>
<fpage>10908</fpage>
<lpage>10912</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.93.20.10908</pub-id>
<pub-id pub-id-type="pmid">8855281</pub-id>
</element-citation>
</ref>
<ref id="B22-cells-08-00090">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moritz</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Ratelade</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes</article-title>
<source/>J. Cell Sci.
          <year>2012</year>
<volume>125</volume>
<fpage>4405</fpage>
<lpage>4412</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.109603</pub-id>
<pub-id pub-id-type="pmid">22718347</pub-id>
</element-citation>
</ref>
<ref id="B23-cells-08-00090">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furman</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Gorelick-Feldman</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Yasumura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Neely</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rash</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 square array assembly: Opposing actions of M1 and M23 isoforms</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2003</year>
<volume>100</volume>
<fpage>13609</fpage>
<lpage>13614</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.2235843100</pub-id>
<pub-id pub-id-type="pmid">14597700</pub-id>
</element-citation>
</ref>
<ref id="B24-cells-08-00090">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crane</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells</article-title>
<source/>J. Biol. Chem.
          <year>2009</year>
<volume>284</volume>
<fpage>35850</fpage>
<lpage>35860</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.071670</pub-id>
<pub-id pub-id-type="pmid">19843522</pub-id>
</element-citation>
</ref>
<ref id="B25-cells-08-00090">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>van Hoek</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Very high single channel water permeability of aquaporin-4 in baculovirus-infected insect cells and liposomes reconstituted with purified aquaporin-4</article-title>
<source/>Biochemistry
          <year>1997</year>
<volume>36</volume>
<fpage>7625</fpage>
<lpage>7632</lpage>
<pub-id pub-id-type="doi">10.1021/bi970231r</pub-id>
<pub-id pub-id-type="pmid">9200715</pub-id>
</element-citation>
</ref>
<ref id="B26-cells-08-00090">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiroaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kamegawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gyobu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Walz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mitsuoka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Implications of the aquaporin-4 structure on array formation and cell adhesion</article-title>
<source/>J. Mol. Biol.
          <year>2006</year>
<volume>355</volume>
<fpage>628</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmb.2005.10.081</pub-id>
<pub-id pub-id-type="pmid">16325200</pub-id>
</element-citation>
</ref>
<ref id="B27-cells-08-00090">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silberstein</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bouley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pastor-Soler</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Van Hoek</surname>
<given-names>A.N.</given-names>
</name>
</person-group>
<article-title>Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells</article-title>
<source/>Am. J. Physiol. Renal Physiol.
          <year>2004</year>
<volume>287</volume>
<fpage>F501</fpage>
<lpage>F511</lpage>
<pub-id pub-id-type="doi">10.1152/ajprenal.00439.2003</pub-id>
<pub-id pub-id-type="pmid">15149973</pub-id>
</element-citation>
</ref>
<ref id="B28-cells-08-00090">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Ratelade</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tradtrantip</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4: Orthogonal array assembly, CNS functions, and role in neuromyelitis optica</article-title>
<source/>Acta Pharmacol. Sin.
          <year>2011</year>
<volume>32</volume>
<fpage>702</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="doi">10.1038/aps.2011.27</pub-id>
<pub-id pub-id-type="pmid">21552296</pub-id>
</element-citation>
</ref>
<ref id="B29-cells-08-00090">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mader</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lutterotti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Di Pauli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kuenz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schanda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Aboul-Enein</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Khalil</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Storch</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Jarius</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kristoferitsch</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica</article-title>
<source/>PLoS ONE
          <year>2010</year>
<volume>5</volume>
<elocation-id>e10455</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0010455</pub-id>
<pub-id pub-id-type="pmid">20463974</pub-id>
</element-citation>
</ref>
<ref id="B30-cells-08-00090">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicchia</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Mastrototaro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pisani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tortorella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ruggieri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trojano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Frigeri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Svelto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies</article-title>
<source/>Glia
          <year>2009</year>
<volume>57</volume>
<fpage>1363</fpage>
<lpage>1373</lpage>
<pub-id pub-id-type="doi">10.1002/glia.20855</pub-id>
<pub-id pub-id-type="pmid">19229993</pub-id>
</element-citation>
</ref>
<ref id="B31-cells-08-00090">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crane</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<fpage>16516</fpage>
<lpage>16524</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.227298</pub-id>
<pub-id pub-id-type="pmid">21454592</pub-id>
</element-citation>
</ref>
<ref id="B32-cells-08-00090">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyazaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Iwanari</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kusano-Arai</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Establishment of monoclonal antibodies against the extracellular domain that block binding of NMO-IgG to AQP4</article-title>
<source/>J. Neuroimmunol.
          <year>2013</year>
<volume>260</volume>
<fpage>107</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2013.03.003</pub-id>
<pub-id pub-id-type="pmid">23746426</pub-id>
</element-citation>
</ref>
<ref id="B33-cells-08-00090">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neely</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Amiry-Moghaddam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Froehner</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2001</year>
<volume>98</volume>
<fpage>14108</fpage>
<lpage>14113</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.241508198</pub-id>
<pub-id pub-id-type="pmid">11717465</pub-id>
</element-citation>
</ref>
<ref id="B34-cells-08-00090">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saadoun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 expression is increased in oedematous human brain tumours</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2002</year>
<volume>72</volume>
<fpage>262</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.72.2.262</pub-id>
<pub-id pub-id-type="pmid">11796780</pub-id>
</element-citation>
</ref>
<ref id="B35-cells-08-00090">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solenov</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Manley</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method</article-title>
<source/>Am. J. Physiol. Cell Physiol.
          <year>2004</year>
<volume>286</volume>
<fpage>C426</fpage>
<lpage>C432</lpage>
<pub-id pub-id-type="doi">10.1152/ajpcell.00298.2003</pub-id>
<pub-id pub-id-type="pmid">14576087</pub-id>
</element-citation>
</ref>
<ref id="B36-cells-08-00090">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haj-Yasein</surname>
<given-names>N.N.</given-names>
</name>
<name>
<surname>Vindedal</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Eilert-Olsen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gundersen</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Skare</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Laake</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Klungland</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thoren</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Burkhardt</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<fpage>17815</fpage>
<lpage>17820</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1110655108</pub-id>
<pub-id pub-id-type="pmid">21990350</pub-id>
</element-citation>
</ref>
<ref id="B37-cells-08-00090">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skucas</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>I.B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Treister</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Duffy</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Hempstead</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>D.K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impairment of select forms of spatial memory and neurotrophin-dependent synaptic plasticity by deletion of glial aquaporin-4</article-title>
<source/>J. Neurosci.
          <year>2011</year>
<volume>31</volume>
<fpage>6392</fpage>
<lpage>6397</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6249-10.2011</pub-id>
<pub-id pub-id-type="pmid">21525279</pub-id>
</element-citation>
</ref>
<ref id="B38-cells-08-00090">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.G.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Glia protein aquaporin-4 regulates aversive motivation of spatial memory in Morris water maze</article-title>
<source/>CNS Neurosci. Ther.
          <year>2013</year>
<volume>19</volume>
<fpage>937</fpage>
<lpage>944</lpage>
<pub-id pub-id-type="doi">10.1111/cns.12191</pub-id>
<pub-id pub-id-type="pmid">24165567</pub-id>
</element-citation>
</ref>
<ref id="B39-cells-08-00090">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice</article-title>
<source/>Neuroreport
          <year>2008</year>
<volume>19</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1097/WNR.0b013e3282f2b4eb</pub-id>
<pub-id pub-id-type="pmid">18281883</pub-id>
</element-citation>
</ref>
<ref id="B40-cells-08-00090">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saadoun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tait</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Reza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology</article-title>
<source/>Neuroscience
          <year>2009</year>
<volume>161</volume>
<fpage>764</fpage>
<lpage>772</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.03.069</pub-id>
<pub-id pub-id-type="pmid">19345723</pub-id>
</element-citation>
</ref>
<ref id="B41-cells-08-00090">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manley</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Fujimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Noshita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Filiz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bollen</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke</article-title>
<source/>Nat. Med.
          <year>2000</year>
<volume>6</volume>
<fpage>159</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1038/72256</pub-id>
<pub-id pub-id-type="pmid">10655103</pub-id>
</element-citation>
</ref>
<ref id="B42-cells-08-00090">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Manley</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema</article-title>
<source/>FASEB J.
          <year>2004</year>
<volume>18</volume>
<fpage>1291</fpage>
<lpage>1293</lpage>
<pub-id pub-id-type="doi">10.1096/fj.04-1723fje</pub-id>
<pub-id pub-id-type="pmid">15208268</pub-id>
</element-citation>
</ref>
<ref id="B43-cells-08-00090">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Wingerchuk</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Kryzer</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Pittock</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Weinshenker</surname>
<given-names>B.G.</given-names>
</name>
</person-group>
<article-title>A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis</article-title>
<source/>Lancet
          <year>2004</year>
<volume>364</volume>
<fpage>2106</fpage>
<lpage>2112</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(04)17551-X</pub-id>
<pub-id pub-id-type="pmid">15589308</pub-id>
</element-citation>
</ref>
<ref id="B44-cells-08-00090">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Kryzer</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Pittock</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Hinson</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel</article-title>
<source/>J. Exp. Med.
          <year>2005</year>
<volume>202</volume>
<fpage>473</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20050304</pub-id>
<pub-id pub-id-type="pmid">16087714</pub-id>
</element-citation>
</ref>
<ref id="B45-cells-08-00090">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarius</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Probst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Borowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Franciotta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wildemann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Stoecker</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wandinger</surname>
<given-names>K.P.</given-names>
</name>
</person-group>
<article-title>Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen</article-title>
<source/>J. Neurol. Sci.
          <year>2010</year>
<volume>291</volume>
<fpage>52</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2010.01.002</pub-id>
<pub-id pub-id-type="pmid">20117794</pub-id>
</element-citation>
</ref>
<ref id="B46-cells-08-00090">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinshenker</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Wingerchuk</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Vukusic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Linbo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pittock</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
</person-group>
<article-title>Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis</article-title>
<source/>Ann. Neurol.
          <year>2006</year>
<volume>59</volume>
<fpage>566</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1002/ana.20770</pub-id>
<pub-id pub-id-type="pmid">16453327</pub-id>
</element-citation>
</ref>
<ref id="B47-cells-08-00090">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wingerchuk</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Banwell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Cabre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chitnis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>de Seze</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>International consensus diagnostic criteria for neuromyelitis optica spectrum disorders</article-title>
<source/>Neurology
          <year>2015</year>
<volume>85</volume>
<fpage>177</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000001729</pub-id>
<pub-id pub-id-type="pmid">26092914</pub-id>
</element-citation>
</ref>
<ref id="B48-cells-08-00090">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palace</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Nairne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Interferon Beta treatment in neuromyelitis optica: Increase in relapses and aquaporin 4 antibody titers</article-title>
<source/>Arch Neurol.
          <year>2010</year>
<volume>67</volume>
<fpage>1016</fpage>
<lpage>1017</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2010.188</pub-id>
<pub-id pub-id-type="pmid">20697055</pub-id>
</element-citation>
</ref>
<ref id="B49-cells-08-00090">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waters</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reindl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saiz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schanda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tuller</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kral</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Nytrova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sobek</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Barington</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multicentre comparison of a diagnostic assay: Aquaporin-4 antibodies in neuromyelitis optica</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2016</year>
<volume>87</volume>
<fpage>1005</fpage>
<lpage>1015</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp-2015-312601</pub-id>
<pub-id pub-id-type="pmid">27113605</pub-id>
</element-citation>
</ref>
<ref id="B50-cells-08-00090">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waters</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>McKeon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Rajasekharan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Villalobos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Palace</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mandrekar</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bar-Or</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays</article-title>
<source/>Neurology
          <year>2012</year>
<volume>78</volume>
<fpage>665</fpage>
<lpage>671</lpage>
<page-range>665–671; discussion 669</page-range>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e318248dec1</pub-id>
<pub-id pub-id-type="pmid">22302543</pub-id>
</element-citation>
</ref>
<ref id="B51-cells-08-00090">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miyazawa</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shiga</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kanaoka</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fujimori</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<fpage>1235</fpage>
<lpage>1243</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awm062</pub-id>
<pub-id pub-id-type="pmid">17449477</pub-id>
</element-citation>
</ref>
<ref id="B52-cells-08-00090">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mader</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gredler</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Schanda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rostasy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dujmovic</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pfaller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lutterotti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jarius</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Pauli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kuenz</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders</article-title>
<source/>J. Neuroinflamm.
          <year>2011</year>
<volume>8</volume>
<fpage>184</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-8-184</pub-id>
<pub-id pub-id-type="pmid">22204662</pub-id>
</element-citation>
</ref>
<ref id="B53-cells-08-00090">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Woodhall</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Palace</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO</article-title>
<source/>Neurol. Neuroimmunol. Neuroinflamm.
          <year>2015</year>
<volume>2</volume>
<fpage>e121</fpage>
<pub-id pub-id-type="doi">10.1212/NXI.0000000000000121</pub-id>
<pub-id pub-id-type="pmid">26140280</pub-id>
</element-citation>
</ref>
<ref id="B54-cells-08-00090">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Pauli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mader</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rostasy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schanda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bajer-Kornek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ehling</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Deisenhammer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reindl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases</article-title>
<source/>Clin. Immunol.
          <year>2011</year>
<volume>138</volume>
<fpage>247</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2010.11.013</pub-id>
<pub-id pub-id-type="pmid">21169067</pub-id>
</element-citation>
</ref>
<ref id="B55-cells-08-00090">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Phuan</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Asavapanumas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tradtrantip</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Biology of AQP4 and anti-AQP4 antibody: Therapeutic implications for NMO</article-title>
<source/>Brain Pathol.
          <year>2013</year>
<volume>23</volume>
<fpage>684</fpage>
<lpage>695</lpage>
<pub-id pub-id-type="doi">10.1111/bpa.12085</pub-id>
<pub-id pub-id-type="pmid">24118484</pub-id>
</element-citation>
</ref>
<ref id="B56-cells-08-00090">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fryer</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Pittock</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Fallier-Becker</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Clardy</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Horta</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jedynak</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Shuster</surname>
<given-names>E.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>AQP4 autoantibody assay performance in clinical laboratory service</article-title>
<source/>Neurol. Neuroimmunol. Neuroinflamm.
          <year>2014</year>
<volume>1</volume>
<fpage>e11</fpage>
<pub-id pub-id-type="doi">10.1212/NXI.0000000000000011</pub-id>
<pub-id pub-id-type="pmid">25340055</pub-id>
</element-citation>
</ref>
<ref id="B57-cells-08-00090">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kusano-Arai</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ramadhanti</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Iwanari</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Miyauchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sakihama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hamakubo</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosis</article-title>
<source/>Biochem. Biophys. Rep.
          <year>2016</year>
<volume>7</volume>
<fpage>77</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrep.2016.05.017</pub-id>
<pub-id pub-id-type="pmid">28955892</pub-id>
</element-citation>
</ref>
<ref id="B58-cells-08-00090">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lassmann</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Oligodendrocytes: Biology and pathology</article-title>
<source/>Acta Neuropathol.
          <year>2010</year>
<volume>119</volume>
<fpage>37</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-009-0601-5</pub-id>
<pub-id pub-id-type="pmid">19847447</pub-id>
</element-citation>
</ref>
<ref id="B59-cells-08-00090">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mader</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reindl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adzemovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo</article-title>
<source/>Ann. Neurol.
          <year>2009</year>
<volume>66</volume>
<fpage>630</fpage>
<lpage>643</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21837</pub-id>
<pub-id pub-id-type="pmid">19937948</pub-id>
</element-citation>
</ref>
<ref id="B60-cells-08-00090">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kalluri</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Saikali</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bautista</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dupree</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Glogowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Antel</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>G.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica</article-title>
<source/>Ann. Neurol.
          <year>2009</year>
<volume>66</volume>
<fpage>617</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21802</pub-id>
<pub-id pub-id-type="pmid">19938104</pub-id>
</element-citation>
</ref>
<ref id="B61-cells-08-00090">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pohl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kitic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Machado-Santos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mader</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ellwart</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>T cell-activation in neuromyelitis optica lesions plays a role in their formation</article-title>
<source/>Acta Neuropathol. Commun.
          <year>2013</year>
<volume>1</volume>
<fpage>85</fpage>
<pub-id pub-id-type="doi">10.1186/2051-5960-1-85</pub-id>
<pub-id pub-id-type="pmid">24367907</pub-id>
</element-citation>
</ref>
<ref id="B62-cells-08-00090">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pohl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Mader</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schanda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kitic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wimmer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Reindl</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathogenic T cell responses against aquaporin 4</article-title>
<source/>Acta Neuropathol.
          <year>2011</year>
<volume>122</volume>
<fpage>21</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-011-0824-0</pub-id>
<pub-id pub-id-type="pmid">21468722</pub-id>
</element-citation>
</ref>
<ref id="B63-cells-08-00090">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica</article-title>
<source/>Acta Neuropathol. Commun.
          <year>2015</year>
<volume>3</volume>
<fpage>28</fpage>
<pub-id pub-id-type="doi">10.1186/s40478-015-0207-1</pub-id>
<pub-id pub-id-type="pmid">25990016</pub-id>
</element-citation>
</ref>
<ref id="B64-cells-08-00090">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schaller</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Cotleur</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Kellner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Takeshita</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Obermeier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kryzer</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kanda</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica</article-title>
<source/>Sci. Transl. Med.
          <year>2017</year>
<volume>9</volume>
<fpage>eaai9111</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.aai9111</pub-id>
<pub-id pub-id-type="pmid">28679661</pub-id>
</element-citation>
</ref>
<ref id="B65-cells-08-00090">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hillebrand</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schanda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nigritinou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsymala</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bohm</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Peschl</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat</article-title>
<source/>Acta Neuropathol.
          <year>2018</year>
<fpage>1</fpage>
<lpage>19</lpage>
</element-citation>
</ref>
<ref id="B66-cells-08-00090">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeshita</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Obermeier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cotleur</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Spampinato</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kryzer</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Kanda</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro</article-title>
<source/>Neurol. Neuroimmunol. Neuroinflamm.
          <year>2017</year>
<volume>4</volume>
<fpage>e311</fpage>
<pub-id pub-id-type="doi">10.1212/NXI.0000000000000311</pub-id>
<pub-id pub-id-type="pmid">28018943</pub-id>
</element-citation>
</ref>
<ref id="B67-cells-08-00090">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yick</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>O.K.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 Autoantibodies from Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice</article-title>
<source/>Front. Immunol.
          <year>2018</year>
<volume>9</volume>
<fpage>1438</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.01438</pub-id>
<pub-id pub-id-type="pmid">29988553</pub-id>
</element-citation>
</ref>
<ref id="B68-cells-08-00090">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishiyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nuriya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yasui</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Itoyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica</article-title>
<source/>Biochem. Biophys. Rep.
          <year>2016</year>
<volume>7</volume>
<fpage>45</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrep.2016.05.012</pub-id>
<pub-id pub-id-type="pmid">29114578</pub-id>
</element-citation>
</ref>
<ref id="B69-cells-08-00090">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinson</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Pittock</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Roemer</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Fryer</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Kryzer</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
</person-group>
<article-title>Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica</article-title>
<source/>Neurology
          <year>2007</year>
<volume>69</volume>
<fpage>2221</fpage>
<lpage>2231</lpage>
<pub-id pub-id-type="doi">10.1212/01.WNL.0000289761.64862.ce</pub-id>
<pub-id pub-id-type="pmid">17928579</pub-id>
</element-citation>
</ref>
<ref id="B70-cells-08-00090">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Mandler</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>McGavern</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bruck</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gleich</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Trebst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Weinshenker</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wingerchuk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Parisi</surname>
<given-names>J.E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica</article-title>
<source/>Brain
          <year>2002</year>
<volume>125</volume>
<fpage>1450</fpage>
<lpage>1461</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awf151</pub-id>
<pub-id pub-id-type="pmid">12076996</pub-id>
</element-citation>
</ref>
<ref id="B71-cells-08-00090">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Treatment of neuromyelitis optica: State-of-the-art and emerging therapies</article-title>
<source/>Nat. Rev. Neurol.
          <year>2014</year>
<volume>10</volume>
<fpage>493</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2014.141</pub-id>
<pub-id pub-id-type="pmid">25112508</pub-id>
</element-citation>
</ref>
<ref id="B72-cells-08-00090">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Basse</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Barmada</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>N.K.</given-names>
</name>
</person-group>
<article-title>Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors</article-title>
<source/>Cancer Immunol. Immunother.
          <year>2000</year>
<volume>49</volume>
<fpage>259</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1007/s002620000120</pub-id>
<pub-id pub-id-type="pmid">10941909</pub-id>
</element-citation>
</ref>
<ref id="B73-cells-08-00090">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saadoun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice</article-title>
<source/>Brain
          <year>2010</year>
<volume>133</volume>
<fpage>349</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awp309</pub-id>
<pub-id pub-id-type="pmid">20047900</pub-id>
</element-citation>
</ref>
<ref id="B74-cells-08-00090">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nytrova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Potlukova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kemlink</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Woodhall</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Horakova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Havrdova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zivorova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trendelenburg</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Complement activation in patients with neuromyelitis optica</article-title>
<source/>J. Neuroimmunol.
          <year>2014</year>
<volume>274</volume>
<fpage>185</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2014.07.001</pub-id>
<pub-id pub-id-type="pmid">25109258</pub-id>
</element-citation>
</ref>
<ref id="B75-cells-08-00090">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hoftberger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wimmer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Konno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bradl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Garzuly</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica</article-title>
<source/>Acta Neuropathol.
          <year>2013</year>
<volume>125</volume>
<fpage>815</fpage>
<lpage>827</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1116-7</pub-id>
<pub-id pub-id-type="pmid">23579868</pub-id>
</element-citation>
</ref>
<ref id="B76-cells-08-00090">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratelade</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Asavapanumas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Wemlinger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica</article-title>
<source/>Acta Neuropathol.
          <year>2013</year>
<volume>126</volume>
<fpage>699</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1172-z</pub-id>
<pub-id pub-id-type="pmid">23995423</pub-id>
</element-citation>
</ref>
<ref id="B77-cells-08-00090">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trebst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jarius</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Berthele</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schippling</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wildemann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Borisow</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kleiter</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aktas</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kumpfel</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)</article-title>
<source/>J. Neurol.
          <year>2014</year>
<volume>261</volume>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-013-7169-7</pub-id>
<pub-id pub-id-type="pmid">24272588</pub-id>
</element-citation>
</ref>
<ref id="B78-cells-08-00090">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleiter</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gahlen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Borisow</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wernecke</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Wegner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hellwig</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pache</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ruprecht</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Havla</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses</article-title>
<source/>Ann. Neurol.
          <year>2016</year>
<volume>79</volume>
<fpage>206</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1002/ana.24554</pub-id>
<pub-id pub-id-type="pmid">26537743</pub-id>
</element-citation>
</ref>
<ref id="B79-cells-08-00090">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cree</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Waubant</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Genain</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>An open label study of the effects of rituximab in neuromyelitis optica</article-title>
<source/>Neurology
          <year>2005</year>
<volume>64</volume>
<fpage>1270</fpage>
<lpage>1272</lpage>
<pub-id pub-id-type="doi">10.1212/01.WNL.0000159399.81861.D5</pub-id>
<pub-id pub-id-type="pmid">15824362</pub-id>
</element-citation>
</ref>
<ref id="B80-cells-08-00090">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gredler</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mader</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schanda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hegen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Di Pauli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kuenz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Deisenhammer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Reindl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lutterotti</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases</article-title>
<source/>J. Neurol. Sci.
          <year>2013</year>
<volume>328</volume>
<fpage>77</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2013.02.024</pub-id>
<pub-id pub-id-type="pmid">23522498</pub-id>
</element-citation>
</ref>
<ref id="B81-cells-08-00090">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mealy</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jimenez Arango</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wingerchuk</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders</article-title>
<source/>Mult. Scler.
          <year>2018</year>
<volume>24</volume>
<fpage>1737</fpage>
<lpage>1742</lpage>
<pub-id pub-id-type="doi">10.1177/1352458517730131</pub-id>
<pub-id pub-id-type="pmid">28857723</pub-id>
</element-citation>
</ref>
<ref id="B82-cells-08-00090">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sfikakis</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Souliotis</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Fragiadaki</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Moutsopoulos</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Boletis</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Theofilopoulos</surname>
<given-names>A.N.</given-names>
</name>
</person-group>
<article-title>Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis</article-title>
<source/>Clin. Immunol.
          <year>2007</year>
<volume>123</volume>
<fpage>66</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2006.12.006</pub-id>
<pub-id pub-id-type="pmid">17275413</pub-id>
</element-citation>
</ref>
<ref id="B83-cells-08-00090">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reis</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Athanazio</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Oliveira e Silva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Jesus</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Barbosa</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Santiago</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis</article-title>
<source/>Rheumatol. Int.
          <year>2009</year>
<volume>29</volume>
<fpage>469</fpage>
<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1007/s00296-008-0719-0</pub-id>
<pub-id pub-id-type="pmid">18821073</pub-id>
</element-citation>
</ref>
<ref id="B84-cells-08-00090">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tradtrantip</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Saadoun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Phuan</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica</article-title>
<source/>Ann. Neurol.
          <year>2012</year>
<volume>71</volume>
<fpage>314</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22657</pub-id>
<pub-id pub-id-type="pmid">22271321</pub-id>
</element-citation>
</ref>
<ref id="B85-cells-08-00090">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soltys</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Restrepo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Determining the Spatial Relationship of Membrane-Bound Aquaporin-4 Autoantibodies by STED Nanoscopy</article-title>
<source/>Biophys. J.
          <year>2017</year>
<volume>112</volume>
<fpage>1692</fpage>
<lpage>1702</lpage>
<pub-id pub-id-type="doi">10.1016/j.bpj.2017.03.012</pub-id>
<pub-id pub-id-type="pmid">28445760</pub-id>
</element-citation>
</ref>
<ref id="B86-cells-08-00090">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Enno</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Del Bigio</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Aquaporin 4 changes in rat brain with severe hydrocephalus</article-title>
<source/>Eur. J. Neurosci.
          <year>2006</year>
<volume>23</volume>
<fpage>2929</fpage>
<lpage>2936</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04829.x</pub-id>
<pub-id pub-id-type="pmid">16819982</pub-id>
</element-citation>
</ref>
<ref id="B87-cells-08-00090">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skjolding</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Rowland</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Sogaard</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Praetorius</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Penkowa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Juhler</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Hydrocephalus induces dynamic spatiotemporal regulation of aquaporin-4 expression in the rat brain</article-title>
<source/>Cereb. Fluid Res.
          <year>2010</year>
<volume>7</volume>
<fpage>20</fpage>
<pub-id pub-id-type="doi">10.1186/1743-8454-7-20</pub-id>
<pub-id pub-id-type="pmid">21054845</pub-id>
</element-citation>
</ref>
<ref id="B88-cells-08-00090">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tourdias</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dragonu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fushimi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Deloire</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Boiziau</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brochet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moonen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Petry</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Dousset</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Aquaporin 4 correlates with apparent diffusion coefficient and hydrocephalus severity in the rat brain: A combined MRI-histological study</article-title>
<source/>Neuroimage
          <year>2009</year>
<volume>47</volume>
<fpage>659</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.04.070</pub-id>
<pub-id pub-id-type="pmid">19409501</pub-id>
</element-citation>
</ref>
<ref id="B89-cells-08-00090">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloch</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Auguste</surname>
<given-names>K.I.</given-names>
</name>
<name>
<surname>Manley</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2006</year>
<volume>26</volume>
<fpage>1527</fpage>
<lpage>1537</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600306</pub-id>
<pub-id pub-id-type="pmid">16552421</pub-id>
</element-citation>
</ref>
<ref id="B90-cells-08-00090">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castaneyra-Ruiz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gonzalez-Marrero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gonzalez-Toledo</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Castaneyra-Ruiz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Paz-Carmona</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Castaneyra-Perdomo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carmona-Calero</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 expression in the cerebrospinal fluid in congenital human hydrocephalus</article-title>
<source/>Fluids Barriers CNS
          <year>2013</year>
<volume>10</volume>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1186/2045-8118-10-18</pub-id>
<pub-id pub-id-type="pmid">23659378</pub-id>
</element-citation>
</ref>
<ref id="B91-cells-08-00090">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clardy</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Krecke</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>O’Toole</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Weinshenker</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Krieger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McGraw</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hydrocephalus in neuromyelitis optica</article-title>
<source/>Neurology
          <year>2014</year>
<volume>82</volume>
<fpage>1841</fpage>
<lpage>1843</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000000428</pub-id>
<pub-id pub-id-type="pmid">24759842</pub-id>
</element-citation>
</ref>
<ref id="B92-cells-08-00090">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magana</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Matiello</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pittock</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>McKeon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Rabinstein</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Shuster</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kantarci</surname>
<given-names>O.H.</given-names>
</name>
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Weinshenker</surname>
<given-names>B.G.</given-names>
</name>
</person-group>
<article-title>Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders</article-title>
<source/>Neurology
          <year>2009</year>
<volume>72</volume>
<fpage>712</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000343001.36493.ae</pub-id>
<pub-id pub-id-type="pmid">19237699</pub-id>
</element-citation>
</ref>
<ref id="B93-cells-08-00090">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iliff</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Plogg</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gundersen</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Benveniste</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vates</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Deane</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>S.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta</article-title>
<source/>Sci. Transl. Med.
          <year>2012</year>
<volume>4</volume>
<fpage>147ra111</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3003748</pub-id>
<pub-id pub-id-type="pmid">22896675</pub-id>
</element-citation>
</ref>
<ref id="B94-cells-08-00090">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Mestre</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The glymphatic pathway in neurological disorders</article-title>
<source/>Lancet Neurol.
          <year>2018</year>
<volume>17</volume>
<fpage>1016</fpage>
<lpage>1024</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(18)30318-1</pub-id>
<pub-id pub-id-type="pmid">30353860</pub-id>
</element-citation>
</ref>
<ref id="B95-cells-08-00090">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karran</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mercken</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>De Strooper</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The amyloid cascade hypothesis for Alzheimer’s disease: An appraisal for the development of therapeutics</article-title>
<source/>Nat. Rev. Drug Discov.
          <year>2011</year>
<volume>10</volume>
<fpage>698</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1038/nrd3505</pub-id>
<pub-id pub-id-type="pmid">21852788</pub-id>
</element-citation>
</ref>
<ref id="B96-cells-08-00090">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shokri-Kojori</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Wiers</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Demiral</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Lindgren</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zehra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>beta-Amyloid accumulation in the human brain after one night of sleep deprivation</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>4483</fpage>
<lpage>4488</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1721694115</pub-id>
<pub-id pub-id-type="pmid">29632177</pub-id>
</element-citation>
</ref>
<ref id="B97-cells-08-00090">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rainey-Smith</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Mazzucchelli</surname>
<given-names>G.N.</given-names>
</name>
<name>
<surname>Villemagne</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Weinborn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bucks</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Milicic</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sohrabi</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Taddei</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Abeta-amyloid burden</article-title>
<source/>Transl. Psychiatry
          <year>2018</year>
<volume>8</volume>
<fpage>47</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-018-0094-x</pub-id>
<pub-id pub-id-type="pmid">29479071</pub-id>
</element-citation>
</ref>
<ref id="B98-cells-08-00090">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>The “glymphatic” mechanism for solute clearance in Alzheimer’s disease: Game changer or unproven speculation?</article-title>
<source/>FASEB J.
          <year>2018</year>
<volume>32</volume>
<fpage>543</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201700999</pub-id>
<pub-id pub-id-type="pmid">29101220</pub-id>
</element-citation>
</ref>
<ref id="B99-cells-08-00090">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.X.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z.L.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic ceftriaxone treatment rescues hippocampal memory deficit in AQP4 knockout mice via activation of GLT-1</article-title>
<source/>Neuropharmacology
          <year>2013</year>
<volume>75</volume>
<fpage>213</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.08.009</pub-id>
<pub-id pub-id-type="pmid">23973312</pub-id>
</element-citation>
</ref>
<ref id="B100-cells-08-00090">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jessen</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Munk</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Lundgaard</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The Glymphatic System: A Beginner’s Guide</article-title>
<source/>Neurochem. Res.
          <year>2015</year>
<volume>40</volume>
<fpage>2583</fpage>
<lpage>2599</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-015-1581-6</pub-id>
<pub-id pub-id-type="pmid">25947369</pub-id>
</element-citation>
</ref>
<ref id="B101-cells-08-00090">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louveau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Plog</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Antila</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alitalo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kipnis</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Understanding the functions and relationships of the glymphatic system and meningeal lymphatics</article-title>
<source/>J. Clin. Investig.
          <year>2017</year>
<volume>127</volume>
<fpage>3210</fpage>
<lpage>3219</lpage>
<pub-id pub-id-type="doi">10.1172/JCI90603</pub-id>
<pub-id pub-id-type="pmid">28862640</pub-id>
</element-citation>
</ref>
<ref id="B102-cells-08-00090">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>X.N.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2007</year>
<volume>34</volume>
<fpage>34</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2006.09.008</pub-id>
<pub-id pub-id-type="pmid">17074507</pub-id>
</element-citation>
</ref>
<ref id="B103-cells-08-00090">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Potential utility of aquaporin modulators for therapy of brain disorders</article-title>
<source/>Prog. Brain Res.
          <year>2008</year>
<volume>170</volume>
<fpage>589</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="pmid">18655912</pub-id>
</element-citation>
</ref>
<ref id="B104-cells-08-00090">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirici</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Balsanu</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Bogdan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Margaritescu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Divan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vitalie</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mogoanta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pirici</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Carare</surname>
<given-names>R.O.</given-names>
</name>
<name>
<surname>Muresanu</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Inhibition of Aquaporin-4 Improves the Outcome of Ischaemic Stroke and Modulates Brain Paravascular Drainage Pathways</article-title>
<source/>Int. J. Mol. Sci.
          <year>2017</year>
<volume>19</volume>
<elocation-id>46</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19010046</pub-id>
<pub-id pub-id-type="pmid">29295526</pub-id>
</element-citation>
</ref>
<ref id="B105-cells-08-00090">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kakita</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Konno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Itoyama</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<fpage>1224</fpage>
<lpage>1234</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awm047</pub-id>
<pub-id pub-id-type="pmid">17405762</pub-id>
</element-citation>
</ref>
<ref id="B106-cells-08-00090">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tradtrantip</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Felix</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Spirig</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica</article-title>
<source/>Neuropharmacology
          <year>2018</year>
<volume>133</volume>
<fpage>345</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.02.002</pub-id>
<pub-id pub-id-type="pmid">29428821</pub-id>
</element-citation>
</ref>
<ref id="B107-cells-08-00090">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Abeta accumulation and memory deficits</article-title>
<source/>Mol. Neurodegener.
          <year>2015</year>
<volume>10</volume>
<fpage>58</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-015-0056-1</pub-id>
<pub-id pub-id-type="pmid">26526066</pub-id>
</element-citation>
</ref>
<ref id="B108-cells-08-00090">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foglio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rodella</surname>
<given-names>L.F.</given-names>
</name>
</person-group>
<article-title>Aquaporins and neurodegenerative diseases</article-title>
<source/>Curr. Neuropharmacol.
          <year>2010</year>
<volume>8</volume>
<fpage>112</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.2174/157015910791233150</pub-id>
<pub-id pub-id-type="pmid">21119882</pub-id>
</element-citation>
</ref>
<ref id="B109-cells-08-00090">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe-Matsumoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moriwaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Okuda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ohara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yasui</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Misawa</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis</article-title>
<source/>Neurosci. Res.
          <year>2018</year>
<volume>133</volume>
<fpage>48</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2017.11.001</pub-id>
<pub-id pub-id-type="pmid">29154923</pub-id>
</element-citation>
</ref>
<ref id="B110-cells-08-00090">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prydz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stahl</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Puchades</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davarpaneh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nadeem</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Gundersen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Amiry-Moghaddam</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Subcellular expression of aquaporin-4 in substantia nigra of normal and MPTP-treated mice</article-title>
<source/>Neuroscience
          <year>2017</year>
<volume>359</volume>
<fpage>258</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.07.029</pub-id>
<pub-id pub-id-type="pmid">28735099</pub-id>
</element-citation>
</ref>
<ref id="B111-cells-08-00090">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tsunoda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishizawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ugawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kakita</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson’s Disease</article-title>
<source/>Brain Pathol.
          <year>2017</year>
<volume>27</volume>
<fpage>160</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1111/bpa.12369</pub-id>
<pub-id pub-id-type="pmid">26919570</pub-id>
</element-citation>
</ref>
<ref id="B112-cells-08-00090">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation</article-title>
<source/>Neurobiol. Aging
          <year>2008</year>
<volume>29</volume>
<fpage>1226</fpage>
<lpage>1236</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2007.02.015</pub-id>
<pub-id pub-id-type="pmid">17353068</pub-id>
</element-citation>
</ref>
<ref id="B113-cells-08-00090">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desai</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Schneller</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hobbs</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Linninger</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Hydrocephalus: The role of cerebral aquaporin-4 channels and computational modeling considerations of cerebrospinal fluid</article-title>
<source/>Neurosurg. Focus
          <year>2016</year>
<volume>41</volume>
<fpage>E8</fpage>
<pub-id pub-id-type="doi">10.3171/2016.7.FOCUS16191</pub-id>
<pub-id pub-id-type="pmid">27581320</pub-id>
</element-citation>
</ref>
<ref id="B114-cells-08-00090">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tome-Garcia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Erfani</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nudelman</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tsankov</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Katsyv</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tejero</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Friedel</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Zaslavsky</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>4020</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-06258-2</pub-id>
<pub-id pub-id-type="pmid">30275445</pub-id>
</element-citation>
</ref>
<ref id="B115-cells-08-00090">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maugeri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schiera</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Di Liegro</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Fricano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iacopino</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Di Liegro</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Aquaporins and Brain Tumors</article-title>
<source/>Int. J. Mol. Sci.
          <year>2016</year>
<volume>17</volume>
<fpage>778</fpage>
<lpage>784</lpage>
<pub-id pub-id-type="doi">10.3390/ijms17071029</pub-id>
<pub-id pub-id-type="pmid">27367682</pub-id>
</element-citation>
</ref>
<ref id="B116-cells-08-00090">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Byne</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Roussos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Siever</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia</article-title>
<source/>Neuropsychopharmacology
          <year>2011</year>
<volume>36</volume>
<fpage>1171</fpage>
<lpage>1177</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2010.252</pub-id>
<pub-id pub-id-type="pmid">21270770</pub-id>
</element-citation>
</ref>
<ref id="B117-cells-08-00090">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Javier Miguel-Hidalgo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Maciag</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder</article-title>
<source/>Biol. Psychiatry
          <year>2013</year>
<volume>73</volume>
<fpage>613</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2012.09.024</pub-id>
<pub-id pub-id-type="pmid">23146357</pub-id>
</element-citation>
</ref>
<ref id="B118-cells-08-00090">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mane</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy</article-title>
<source/>Acta Neuropathol.
          <year>2004</year>
<volume>108</volume>
<fpage>493</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-004-0910-7</pub-id>
<pub-id pub-id-type="pmid">15517312</pub-id>
</element-citation>
</ref>
<ref id="B119-cells-08-00090">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Binder</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Oshio</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Verkman</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Manley</surname>
<given-names>G.T.</given-names>
</name>
</person-group>
<article-title>Increased seizure threshold in mice lacking aquaporin-4 water channels</article-title>
<source/>Neuroreport
          <year>2004</year>
<volume>15</volume>
<fpage>259</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200402090-00009</pub-id>
<pub-id pub-id-type="pmid">15076748</pub-id>
</element-citation>
</ref>
<ref id="B120-cells-08-00090">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edmonson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ziats</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Rennert</surname>
<given-names>O.M.</given-names>
</name>
</person-group>
<article-title>Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum</article-title>
<source/>Mol. Autism
          <year>2014</year>
<volume>5</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-3</pub-id>
<pub-id pub-id-type="pmid">24410870</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="cells-08-00090-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Multiple mechanisms for AQP4-IgG access to the brain: Insights from rodent models. Cross section of a blood vessel demonstrating how AQP4-IgG can enter the brain according to findings from rodent models. BBB breach can occur through encephalitogenic CNS reactive T cells [<xref ref-type="bibr" rid="B59-cells-08-00090">59</xref>,<xref ref-type="bibr" rid="B60-cells-08-00090">60</xref>], inflammatory agents [<xref ref-type="bibr" rid="B67-cells-08-00090">67</xref>] (LPS, TNF alpha, IL-1) and antibodies that alter endothelial cells functional (e.g., anti-GRP78 antibodies [<xref ref-type="bibr" rid="B64-cells-08-00090">64</xref>]). Recently, it was postulated that high affinity AQP4-IgG could enter the brain through circumventricular organs and meningeal or even parenchymal blood vessels without prior BBB insult [<xref ref-type="bibr" rid="B65-cells-08-00090">65</xref>].</p>
</caption>
<graphic xlink:href="cells-08-00090-g001"></graphic>
</fig>
<fig id="cells-08-00090-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>AQP4 mediates-waste clearance through the glymphatic system. In the healthy brain, AQP4 is mainly expressed on astrocyte endfeet (polarized AQP4 expression). CSF circulates through the para-arterial system (para-arterial influx) into the brain parenchyma and then into the veins (para-arterial efflux). With aging, and even more so under pathologic conditions, AQP4 polarization is reduced and there is more expression of AQP4 on parenchymal processes (AQP4 depolarization), which affects the efficiency of the glymphatic system in waste clearance such as beta-amyloid. Accumulation of beta-amyloid is a hallmark of AD [<xref ref-type="bibr" rid="B98-cells-08-00090">98</xref>]. Image modified from [<xref ref-type="bibr" rid="B100-cells-08-00090">100</xref>,<xref ref-type="bibr" rid="B101-cells-08-00090">101</xref>].</p>
</caption>
<graphic xlink:href="cells-08-00090-g002"></graphic>
</fig>
<table-wrap id="cells-08-00090-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">cells-08-00090-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>AQP4 in different pathological conditions.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disease</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Mechanism</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">AQP4 Related Pathology</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Rodent Models</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">(Potential) Therapeutic </th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>NMOSD</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">-AQP4-IgG dependent tissue astrocytophathy: <break></break>-CDC<break></break>-ADCC<break></break>-other mechanisms</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">-Presence of AQP4-IgG in serum [<xref ref-type="bibr" rid="B44-cells-08-00090">44</xref>]<break></break>-Loss of AQP4 in NMOSD lesions [<xref ref-type="bibr" rid="B105-cells-08-00090">105</xref>]<break></break>-Massive demyelination (brain, optic nerve, spinal cord) [<xref ref-type="bibr" rid="B70-cells-08-00090">70</xref>,<xref ref-type="bibr" rid="B75-cells-08-00090">75</xref>] </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">1. Injection of anti-AQP4-IgG into the brain [<xref ref-type="bibr" rid="B73-cells-08-00090">73</xref>]<break></break>2. Intravenous injection of AQP4-IgG following BBB disruption through T cell- mediated EAE [<xref ref-type="bibr" rid="B59-cells-08-00090">59</xref>,<xref ref-type="bibr" rid="B60-cells-08-00090">60</xref>], bacterial proteins [<xref ref-type="bibr" rid="B67-cells-08-00090">67</xref>] or anti-endothelial antibody [<xref ref-type="bibr" rid="B64-cells-08-00090">64</xref>]. <break></break>3. High affinity circulating rodent AQP4-IgG enter the CNS without BBB impairment [<xref ref-type="bibr" rid="B65-cells-08-00090">65</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">-Decoy antibody lacking FcR or complement binding [<xref ref-type="bibr" rid="B84-cells-08-00090">84</xref>]<break></break>-Recombinant IgG1 Fc hexamers that block cytotoxicity and pathological changes [<xref ref-type="bibr" rid="B106-cells-08-00090">106</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Alzheimer’s Disease</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Loss of AQP4 polarization with impaired clearance of interstitial solutes and increased aggregation (beta- amyloid)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Mislocalization of AQP4 [<xref ref-type="bibr" rid="B13-cells-08-00090">13</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 gene knockout of beta-amyloid precursor protein /presenilin 1 (APP/PS1) transgenic mice [<xref ref-type="bibr" rid="B107-cells-08-00090">107</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 receptor agonists [<xref ref-type="bibr" rid="B107-cells-08-00090">107</xref>] </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>ALS</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Loss of AQP4 polarization and altered AQP4 expression is contributing to motor neuron degeneration [<xref ref-type="bibr" rid="B107-cells-08-00090">107</xref>] and BBB impairment [<xref ref-type="bibr" rid="B108-cells-08-00090">108</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 overexpression in astrocytes [<xref ref-type="bibr" rid="B109-cells-08-00090">109</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Superoxide dismutase 1 (SOD1) G93A transgenic mice (mouse model of ALS) [<xref ref-type="bibr" rid="B109-cells-08-00090">109</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Targeting AQP4 as potential treatment to restore BBB in ALS [<xref ref-type="bibr" rid="B108-cells-08-00090">108</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Parkinson’s Disease (PD)</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 dysfunction contributing to synuclein deposition and water accumulation in the substantia nigra [<xref ref-type="bibr" rid="B110-cells-08-00090">110</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Enriched AQP4-positive astrocytes in the neocortex [<xref ref-type="bibr" rid="B111-cells-08-00090">111</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 deficient mice treated with MPTP [<xref ref-type="bibr" rid="B112-cells-08-00090">112</xref>] </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Ischemic Stroke</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 enhances edema formation or diminishes resolution</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Enhanced expression of AQP4 at site of infarction [<xref ref-type="bibr" rid="B10-cells-08-00090">10</xref>].</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Brain edema caused by acute water intoxication using AQP4 knock out mice [<xref ref-type="bibr" rid="B41-cells-08-00090">41</xref>] </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 inhibitors during edema formation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Traumatic brain injury (TBI)</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 is altering water homeostasis and AQP4 may be associated with neuroinflammation (through astrocyte and microglia activation)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Increased expression of AQP4 and loss of AQP4 polarity [<xref ref-type="bibr" rid="B9-cells-08-00090">9</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">TBI mouse model [<xref ref-type="bibr" rid="B9-cells-08-00090">9</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 inhibitors may be beneficial [<xref ref-type="bibr" rid="B103-cells-08-00090">103</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Hydrocephalus</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Control of water homeostasis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">-Increased AQP4 in CSF of congenital communicating hydrocephalus [<xref ref-type="bibr" rid="B90-cells-08-00090">90</xref>], -Hydrocephalus has been reported in AQP4-IgG positive NMOSD [<xref ref-type="bibr" rid="B91-cells-08-00090">91</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Rat kaolin model [<xref ref-type="bibr" rid="B86-cells-08-00090">86</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Increasing AQP4 to support CSF clearance at a later disease stage or decreasing AQP4 in areas of CSF production particularly at disease onset [<xref ref-type="bibr" rid="B113-cells-08-00090">113</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Glioma</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">-AQP4 is contributing to increased tumor cell migration possibly through increasing water permeability [<xref ref-type="bibr" rid="B114-cells-08-00090">114</xref>]. <break></break>-Involvement of AQP4 in tumor edema</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Expression of AQP4 in human glioblastoma [<xref ref-type="bibr" rid="B115-cells-08-00090">115</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Use of AQP inhibitors to reduce tumor growth [<xref ref-type="bibr" rid="B18-cells-08-00090">18</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Schizophrenia</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Reduced AQP4 is contributing to neurovascular dysfunction and BBB hyperpermeability</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Astroglial loss and reduced AQP4 expression in the deep layers of the anterior cingulated gyrus [<xref ref-type="bibr" rid="B116-cells-08-00090">116</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Major depressive disorder (MDD)</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 is contributing to poor water balance </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Reduced coverage of blood vessels by AQP4 positive astrocytic endfeet in the orbitofrontal cortex [<xref ref-type="bibr" rid="B117-cells-08-00090">117</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Epilepsy</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Impairment of K+ homeostasis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 expression is increased in samples from atrophic hippocampus from epileptic patients [<xref ref-type="bibr" rid="B118-cells-08-00090">118</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 deficient mice [<xref ref-type="bibr" rid="B119-cells-08-00090">119</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">AQP4 modulators to increase seizure thresholds [<xref ref-type="bibr" rid="B103-cells-08-00090">103</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Autism</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Abnormal glial-neuronal communication in brains of subjects with autism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Decreased AQP4 expression in cerebellum of post mortem tissue [<xref ref-type="bibr" rid="B120-cells-08-00090">120</xref>]</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">N/A</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>